Correlation Between DiaMedica Therapeutics and Halozyme Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Halozyme Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Halozyme Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Halozyme Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Halozyme is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Halozyme Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Halozyme Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to under-perform the Halozyme Therapeutics. In addition to that, DiaMedica Therapeutics is 2.69 times more volatile than Halozyme Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Halozyme Therapeutics is currently generating about 0.33 per unit of volatility. If you would invest 4,799 in Halozyme Therapeutics on December 30, 2024 and sell it today you would earn a total of 1,585 from holding Halozyme Therapeutics or generate 33.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Halozyme Therapeutics
Performance |
Timeline |
DiaMedica Therapeutics |
Halozyme Therapeutics |
DiaMedica Therapeutics and Halozyme Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Halozyme Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |